Literature DB >> 27567184

Progressive Focal Gray Matter Volume Loss in a Former High School Football Player: A Possible Magnetic Resonance Imaging Volumetric Signature for Chronic Traumatic Encephalopathy.

Cyrus A Raji1, David A Merrill2, Jorge R Barrio3, Bennet Omalu4, Gary W Small2.   

Abstract

Here a case is presented of a 51-year-old former high school football player with multiple concussions, including one episode with loss of consciousness. The patient experienced 6 years of cognitive and mood decline, and his wife corroborated increasing memory loss, attentional difficulties, and depressed mood without suicidal ideation. He had been unable to maintain full-time employment because of progressive decline. Based on his presentation, he had been previously diagnosed with attention deficit hyperactivity disorder and bipolar disorder, type II. Neuropsychological tests indicated domain-specific cognitive impairment, and longitudinal volumetric magnetic resonance imaging (MRI) of the brain showed progressive brainstem, diencephalic, and frontal lobe atrophy. This regional volume loss correlated with the increased signal seen on tau and amyloid imaging (FDDNP-PET scan) of a separate case of suspected chronic traumatic encephalopathy (CTE). Visual assessment of the MRI also showed evidence of old petechial hemorrhages in the frontal and temporal-parietal lobe white matter. This case raises the possibility of distinct quantitative and visual brain MRI findings in suspected CTE.
Copyright © 2016 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CTE; FDDNP; Neuroreader; brain PET; volumetric MRI

Mesh:

Substances:

Year:  2016        PMID: 27567184     DOI: 10.1016/j.jagp.2016.07.018

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  6 in total

1.  MRI Volumetric Quantification in Persons with a History of Traumatic Brain Injury and Cognitive Impairment.

Authors:  Somayeh Meysami; Cyrus A Raji; David A Merrill; Verna R Porter; Mario F Mendez
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Improved Detection of Subtle Mesial Temporal Sclerosis: Validation of a Commercially Available Software for Automated Segmentation of Hippocampal Volume.

Authors:  J M Mettenburg; B F Branstetter; C A Wiley; P Lee; R M Richardson
Journal:  AJNR Am J Neuroradiol       Date:  2019-02-07       Impact factor: 3.825

3.  Brain Structure in Bilingual Compared to Monolingual Individuals with Alzheimer's Disease: Proof of Concept.

Authors:  Cyrus A Raji; Somayeh Meysami; David A Merrill; Verna R Porter; Mario F Mendez
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 4.  Emerging advances of in vivo detection of chronic traumatic encephalopathy and traumatic brain injury.

Authors:  Julian D Dallmeier; Somayeh Meysami; David A Merrill; Cyrus A Raji
Journal:  Br J Radiol       Date:  2019-07-26       Impact factor: 3.039

5.  [18F]FDG, [11C]PiB, and [18F]AV-1451 PET Imaging of Neurodegeneration in Two Subjects With a History of Repetitive Trauma and Cognitive Decline.

Authors:  David O Okonkwo; Ross C Puffer; Davneet S Minhas; Sue R Beers; Kathryn L Edelman; Jane Sharpless; Charles M Laymon; Brian J Lopresti; Steven Benso; Ava M Puccio; Sudhir Pathak; Milos D Ikonomovic; Joseph M Mettenburg; Walter Schneider; Chester A Mathis; James M Mountz
Journal:  Front Neurol       Date:  2019-08-02       Impact factor: 4.003

6.  Assessing brain volume changes in older women with breast cancer receiving adjuvant chemotherapy: a brain magnetic resonance imaging pilot study.

Authors:  Bihong T Chen; Sean K Sethi; Taihao Jin; Sunita K Patel; Ningrong Ye; Can-Lan Sun; Russell C Rockne; E Mark Haacke; James C Root; Andrew J Saykin; Tim A Ahles; Andrei I Holodny; Neal Prakash; Joanne Mortimer; James Waisman; Yuan Yuan; George Somlo; Daneng Li; Richard Yang; Heidi Tan; Vani Katheria; Rachel Morrison; Arti Hurria
Journal:  Breast Cancer Res       Date:  2018-05-02       Impact factor: 6.466

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.